115 related articles for article (PubMed ID: 38676768)
1. Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis.
Agarwal S; Gupta S; Raj R
Endocrine; 2024 Apr; ():. PubMed ID: 38676768
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis.
Sun T; Guan Q; Wang Y; Qian K; Sun W; Ji Q; Wu Y; Guo K; Xiang J
Gland Surg; 2021 Feb; 10(2):629-644. PubMed ID: 33708546
[TBL] [Abstract][Full Text] [Related]
3. Network-based meta-analysis in the identification of biomarkers for papillary thyroid cancer.
Zhao H; Li H
Gene; 2018 Jun; 661():160-168. PubMed ID: 29625265
[TBL] [Abstract][Full Text] [Related]
4. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
5. Integrated Bioinformatics Analysis of Hub Genes and Pathways in Anaplastic Thyroid Carcinomas.
Gao X; Wang J; Zhang S
Int J Endocrinol; 2019; 2019():9651380. PubMed ID: 30774662
[TBL] [Abstract][Full Text] [Related]
6. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
7. Siglec-15 Silencing Inhibits Cell Proliferation and Promotes Cell Apoptosis by Inhibiting STAT1/STAT3 Signaling in Anaplastic Thyroid Carcinoma.
Hou X; Chen C; He X; Lan X
Dis Markers; 2022; 2022():1606404. PubMed ID: 35769818
[TBL] [Abstract][Full Text] [Related]
8. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
9. Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets.
Dong X; Yang Y; Hou J; Chen W; Yuan Q; Xu G; Liu J; Li C; Wu G
Front Oncol; 2022; 12():1018479. PubMed ID: 36530988
[TBL] [Abstract][Full Text] [Related]
10. Key genes involved in cell cycle arrest and DNA damage repair identified in anaplastic thyroid carcinoma using integrated bioinformatics analysis.
Zhang Z; Zou Z; Dai H; Ye R; Di X; Li R; Ha Y; Sun Y; Gan S
Transl Cancer Res; 2020 Jul; 9(7):4188-4203. PubMed ID: 35117787
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Core Genes Involved in the Development of Papillary Thyroid Carcinoma via Bioinformatics Analysis.
Li X; He J; Zhou M; Cao Y; Jin Y; Zou Q
Int J Genomics; 2019; 2019():5894926. PubMed ID: 31583243
[TBL] [Abstract][Full Text] [Related]
12. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network.
Gong Y; Xu F; Deng L; Peng L
Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
Li L; Zhu M; Huang H; Wu J; Meng D
Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
[TBL] [Abstract][Full Text] [Related]
14. Identifying hub genes of papillary thyroid carcinoma in the TCGA and GEO database using bioinformatics analysis.
Wan Y; Zhang X; Leng H; Yin W; Zeng W; Zhang C
PeerJ; 2020; 8():e9120. PubMed ID: 32714651
[TBL] [Abstract][Full Text] [Related]
15. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of potential target genes in papillary thyroid cancer.
Zhang K; Liu J; Li C; Peng X; Li H; Li Z
Eur J Pharmacol; 2019 Jan; 843():217-225. PubMed ID: 30472204
[TBL] [Abstract][Full Text] [Related]
17. Identification of key pathways and biomarkers in anaplastic thyroid cancer using an integrated analysis.
Zhou J; Dong S; Shi C
J BUON; 2020; 25(6):2690-2699. PubMed ID: 33455115
[TBL] [Abstract][Full Text] [Related]
18. Genes and pathways identified in thyroid carcinoma based on bioinformatics analysis.
Yu JW; Mai W; Cui YL; Kong LY
Neoplasma; 2016; 63(4):559-68. PubMed ID: 27268919
[TBL] [Abstract][Full Text] [Related]
19. Uncovering the pathogenesis of obesity complicated with papillary thyroid carcinoma via bioinformatics and experimental validation.
Yuan K; Hu D; Mo X; Zeng R; Wu B; Zhang Z; Hu R; Wang C
Aging (Albany NY); 2023 Sep; 15(17):8729-8743. PubMed ID: 37671970
[TBL] [Abstract][Full Text] [Related]
20. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
